Project Grant 2036188
Award Date
2/15/21
Completion Date
3/31/22
Dollars Obligated
$256K
Funding Federal Agency
National Science Foundation
Awarding Federal Agency
Division of Industrial Innovation
Awardee
Athem LLC (F5X8LV38ETG7)
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Morrisville, NC, USA
Similar Awards
The National Science Foundation Division of Industrial Innovation awarded $255,700 to Creative Biotherapeutics LLC through its Engineering program (CFDA 47.041) on January 15, 2021 to fund the project "SBIR PHASE I: STRESS PATHWAY INHIBITION PREVENTS COVID-19 INFECTION (COVID-19)." This Project Grant will support Creative Biotherapeutics' research efforts through December 31, 2021 to develop inhibitors of stress response pathways to prevent COVID-19 infection. The NSF Engineering...
The National Science Foundation Division of Civil, Mechanical, and Manufacturing Innovation awarded North Carolina State University a $100,000 Project Grant under the Engineering (47.041) federal grant program. The grant supports the RAPID: COLLECTION AND ARCHIVING OF VITAL DATA ON COVID-19 VACCINE DISTRIBUTION project from June 1, 2021 to May 31, 2022. The project will collect and archive vital data on COVID-19 vaccine distribution to support the NSF Directorate for Engineering's goal of...
The National Science Foundation Division of Industrial Innovation awarded MBF Therapeutics Inc. a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) from January 1, 2022 to December 31, 2022. The grant funds the development of a protective T cell vaccine for SARS CoV-2 (COVID-19). The Engineering program supports innovation, creativity and excellence in engineering research and education to improve quality of life and economic strength. This award furthers those...
The National Science Foundation awarded Aural Analytics, Inc. a $256,000 Project Grant under the Engineering (47.041) federal grant program. The grant funded the company's "STTR PHASE I: REMOTE ASSESSMENT OF RESPIRATORY FUNCTION IN HOSPITAL PATIENTS BASED ON SPEECH ACOUSTICS (COVID-19)" project from June 15, 2021 to February 28, 2022. The project aimed to develop technology using speech acoustics to remotely assess respiratory function in hospital patients, which has applications for...
The National Science Foundation awarded a $256,000 Small Business Innovation Research Phase I Project Grant to White Rock Therapeutics under the Engineering federal grant program (CFDA 47.041). The grant will support development of an ACE2 decoy as a pan-coronavirus therapeutic from January 2022 to December 2022. The Engineering program seeks to improve quality of life and economic strength by fostering innovation and excellence in engineering research. This award will fund initial research...
Florica Therapeutics, Inc. was awarded a $275,678 Project Grant from the National Science Foundation Division of Industrial Innovation under the Engineering (47.041) federal grant program. The grant will support research from January 15, 2021 through December 31, 2021 to develop hypothalamus stem cell exosomes for the treatment of COVID-19. As part of its mission to improve lives and economic strength through engineering innovation, the NSF Engineering program aims to foster excellence in...
This $247,457 National Science Foundation project grant funded research on coupling COVID-19 respiratory droplet adsorption and photocatalysis through metal organic frameworks. The grant was awarded to Framergy Inc. on June 15, 2021 under the Engineering (47.041) federal grant program. The objective was to develop materials and techniques to capture and deactivate SARS-CoV-2 virus particles through the end date of November 30, 2021. The Engineering program seeks to improve quality of life and...
The National Science Foundation awarded a $220,000 Project Grant to the University of Connecticut under the Engineering (47.041) federal grant program. The award will fund development of a compact, field-portable biophotonics instrument for automated analysis and identification of blood cells impacted by COVID-19. The instrument aims to provide real-time sensing and diagnosis capabilities with high accuracy, specificity and sensitivity for potential early detection of COVID-19 infections. It...
The National Science Foundation awarded Fibrosix Inc. a $256,000 Project Grant under the Engineering federal grant program (CFDA 47.041) for the period of March 1, 2021 through August 31, 2021. The grant funding supports Fibrosix's "SBIR PHASE I: QUIETING SYSTEMIC HYPER-INFLAMMATION (COVID-19)" project. Specifically, the grant will enable Fibrosix to conduct research towards developing technologies or techniques to reduce excessive inflammation in response to COVID-19 and future...
The National Science Foundation (NSF) awarded a Project Grant of $653,629 to Northeastern University on February 1, 2024 under the Engineering program (CFDA 47.041). The objectives of this 5-year project are to elucidate and optimize the binding affinity between collectins (a class of immune system proteins) and glycans (sugar structures found on pathogens), with the goal of enhancing early detection and response to viral infections like influenza. The research will employ an interdisciplinary...